✨ Free AI Report
QuidelOrtho Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research QuidelOrtho Corporation
Company Research

QuidelOrtho Corporation: Business Overview, Financials & Competitive Analysis

QuidelOrtho Corporation is a global leader of innovative in vitro diagnostics that operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. In 2025, the company transitione...

Analyst-debate audio for QuidelOrtho Corporation

AskCyborg analysts argue the bull and bear cases for QuidelOrtho Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
3/ 10Weak

Cyborg Score thesis

Turnaround play benefiting from margin expansion and cash flow improvement, but facing persistent unprofitability and execution...

Read the full analyst-debate transcript →
Industry Healthcare Diagnostics / In Vitro Diagnostics (IVD)
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest QuidelOrtho Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

QuidelOrtho Corporation Overview

Pro stress-test →

QuidelOrtho Corporation is a global leader of innovative in vitro diagnostics that operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. In 2025, the company transitioned from COVID-driven volatility to a more durable, diversified diagnostics business.

Strategic Profile

Pro stress-test →

Labs, Immunohematology and Cardiac businesses delivered consistent growth, while cost-savings initiatives drove meaningful margin expansion, positioning the company to generate substantially stronger free cash flow in 2026. The company is shifting strategic focus to Labs and non-respiratory growth areas, while acknowledging expected declines, particularly with donor screening winding down by mid-2026.

Competitive Landscape

Pro stress-test →

QuidelOrtho competes in in vitro diagnostics across multiple channels including direct sales and distributor networks to physician offices, hospitals, clinical laboratories, and other healthcare settings. Primary competitors include Siemens Healthineers, Abbott Diagnostics, Roche Diagnostics, Bio-Rad Laboratories, and Ortho Clinical Diagnostics in transfusion medicine and broader diagnostic testing segments.

Industry Context

QuidelOrtho Corporation operates in Healthcare Diagnostics / In Vitro Diagnostics (IVD).

Key facts

Founded: 1979 · Headquarters: San Diego, United States · Revenue: $2.73B

What the analysts stress-tested

The top findings that survived the multi-agent debate for QuidelOrtho Corporation.

  • Full-year 2025 revenue was $2.73 billion, slightly below 2024, as respiratory revenue fell 20% to $402.1 million with lower COVID-19 testing
  • Adjusted EBITDA improved 240 basis points to 22% margin; free cash flow expected to improve by over $200 million in 2026, guiding to $120–$160 million
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026CFO retirement announced with June 30 transition date and advisory role continuation
  • February 2026Q4 2025 earnings beat Wall Street expectations; issued 2026 guidance of $2.7–$2.9B revenue
  • +1 moreTrack every material event for QuidelOrtho Corporation as it happens. Explore monitoring →
Get alerted when QuidelOrtho Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Diagnostics PortfolioBroad diagnostic testing solutions across point-of-care and laboratory→Clinical Laboratory ProductsLeading provider of clinical chemistry and immunoassay diagnostics→Diagnostic Imaging & Lab SystemsComprehensive diagnostic solutions for laboratories and hospitals→

Compare QuidelOrtho Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

QuidelOrtho Corporation operates in Healthcare Diagnostics / In Vitro Diagnostics (IVD). See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Diagnostics / In Vitro Diagnostics (IVD) research →
NEW · MCP server

Ask your AI assistant about QuidelOrtho Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare QuidelOrtho Corporation and its top competitor on Cyborg Score”
“What did QuidelOrtho Corporation do this quarter?”
“Is QuidelOrtho Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does QuidelOrtho Corporation do?+
QuidelOrtho Corporation is a global leader of innovative in vitro diagnostics that operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. In 2025, the company transitione...
What is QuidelOrtho Corporation's Cyborg Score?+
QuidelOrtho Corporation has a Cyborg Score of 3/10 (Weak). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are QuidelOrtho Corporation's main competitors?+
Named competitors include Diagnostics Portfolio, Clinical Laboratory Products, Diagnostic Imaging & Lab Systems. The full competitive landscape is in the AskCyborg report.
How can I get the full QuidelOrtho Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the QuidelOrtho Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track QuidelOrtho Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Healthcare Diagnostics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

3QuidelOrtho Corporation